News Sentiment

DGX sentiment intelligence

Quest Diagnostics Incorporated news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 64 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 210.68 Week of 17 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 64

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

+1.6% over one week, +8.5% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Quest Diagnostics stock trades steadily as investors weigh recent revenue growth and dividend income

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 1.6% Price digesting
Trend fit Trend active 8.5% over four weeks
Fair value 33.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 39
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 64
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Ad-hoc-news.de 9
TradingView 9
Market source 6
PR Newswire 4
MarketWatch 3
Ad Hoc News 3
DirectorsTalk Interviews 3
Stock Titan 3

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 16
Analyst action 7
Capital return 3
Macro sensitivity 2
Regulatory and legal 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 64
TradingView Direct company coverage

Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus

Quest Diagnostics is scheduled to release its second-quarter 2026 earnings on July 23, with analysts expecting revenue growth of 7.9% and an EPS increase of 7.3%. The company's performance is anticipated to be boosted by strong demand across physician, enterprise, and consumer ch

Tone
Positive 73/100
Event
Earnings
Published
14 Jul 2026 14:07
Source
TradingView
TradingView Direct company coverage

Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?

Abbott Laboratories (ABT) is set to release its second-quarter 2026 results on July 16, with analysts expecting a 1.6% EPS growth and 12% revenue increase year-over-year. The company's Diagnostics, Established Pharmaceutical Products, and Medical Devices segments are anticipated

Tone
Positive 61/100
Event
Earnings
Published
14 Jul 2026 13:07
Source
TradingView
Ad Hoc News Direct company coverage

Quest Diagnostics stock holds steady on a broad health care backdrop

Quest Diagnostics (DGX) remains a significant player in the U.S. diagnostics market, providing essential testing services to physicians, hospitals, and employers. The company's business model, which includes routine blood work and specialty diagnostics, positions it as a defensiv

Tone
Positive 60/100
Event
Market update
Published
14 Jul 2026 04:25
Source
Ad Hoc News